The effect of rebamipide for healthy subjects with nonsteroidal anti-inflammatory drug (NSAID)-induced small intestinal injury: a prospective, randomised, double-blinded, placebo-controlled study.
Phase of Trial: Phase III
Latest Information Update: 29 Apr 2011
At a glance
- Drugs Rebamipide (Primary)
- Indications NSAID-induced gastrointestinal damage
- Focus Therapeutic Use
- 29 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ISRCTN.
- 23 Aug 2007 New trial record.